Delta-tocotrienol disrupts PD-L1 glycosylation and reverses PD-L1-mediated immune suppression
Open Access
- 29 December 2023
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 170, 116078
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2023YFF1105202)
- Ministry of Science and Technology of the People's Republic of China
This publication has 43 references indexed in Scilit:
- EGR-1/Bax pathway plays a role in vitamin E δ-tocotrienol-induced apoptosis in pancreatic cancer cellsThe Journal of Nutritional Biochemistry, 2015
- Tocotrienols promote apoptosis in human breast cancer cells by inducing poly(ADP‐ribose) polymerase cleavage and inhibiting nuclear factor kappa‐B activityCell Proliferation, 2013
- Delta‐tocotrienol suppresses Notch‐1 pathway by upregulating miR‐34a in nonsmall cell lung cancer cellsInternational Journal of Cancer, 2012
- Vitamin E δ-Tocotrienol Augments the Antitumor Activity of Gemcitabine and Suppresses Constitutive NF-κB Activation in Pancreatic CancerMolecular Cancer Therapeutics, 2011
- Mechanisms and principles of N-linked protein glycosylationCurrent Opinion in Structural Biology, 2011
- Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathwayFree Radical Biology and Medicine, 2011
- A paraptosis-like cell death induced by δ-tocotrienol in human colon carcinoma SW620 cells is associated with the suppression of the Wnt signaling pathwayToxicology, 2011
- Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other CancersJAMA, 2009
- Vitamins E and C in the Prevention of Prostate and Total Cancer in MenJAMA, 2009
- PD-1 and Its Ligands in Tolerance and ImmunityAnnual Review of Immunology, 2008